Trading Signals: REGN Stock Price Prediction and Forecast (Fri. Mar. 14, 2014 - Fri. Dec. 22, 2023)(Regeneron Pharmaceuticals Inc)
| REGN latest price $632.9000 (1.03%) ($632.9000 - $634.2600) on Fri. Nov. 12, 2021. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 1.93% (three month average) | RSI | 70 | Latest Price | $632.9000(1.03%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | REGN advances 0.7% a day on average for past five trading days. | Weekly Trend | REGN advances 1.4% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Normal for small cap. | Correlated ETFs | Broad market will support REGN advance at 0% a week (0% probability) IBB(53%) XLV(40%) DIA(39%) IWD(38%) SPY(37%) | Factors Impacting REGN price | REGN will decline at least -0.965% in a week (0% probabilities). VIXM(-21%) UUP(-7%) TBT(-7%) VXX(-5%) IGOV(-3%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -0.965% (StdDev 1.93%) | Hourly BBV | 1.8 () | Intraday Trend | 0% | | | |
|
5 Day Moving Average | $624.07(1.41%) | 10 Day Moving Average | $630.28(0.42%) | 20 Day Moving Average | $608.05(4.09%) | To recent high | -7.5% | To recent low | 16.6% | Market Cap | $67.106b | | | | Regeneron Pharmaceuticals, Inc. is a biotechnology company, which engages in the discovery, invention, development, manufacture, and commercialization of medicines. It product portfolio includes the following brands: EYLEA, Dupixent, Praluent, Kevzara, Libtayo, ARCALYST, and ZALTRAP. The company was founded by Alferd G. Gilman, Leonard S. Schleifer, and Eric M. Shooter on January 8, 1988 and is headquartered in Tarrytown, NY. |